BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-19

Study Completion Date

2017-04-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether BVS(Bioresorbable Vascular Scaffold) implantation with optimal medical therapy can improve the outcome of patients with variant angina and moderate coronary artery disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

HOW To Optimally Implant BioResorbable Scaffold - Intravascular Imaging Versus Quantitative Coronary Angiography Guidance

NCT03175523

Coronary Stenosis

TERMINATED NA

Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold

NCT02162056

Coronary Artery Disease Ischemic Heart Disease Stable Angina +2 more

COMPLETED NA

Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina

NCT02707783

Angina

COMPLETED

Plaque Stabilization and Restoration by Bioresorbable Vascular Scaffold

NCT02319733

Vulnerable Plaque

TERMINATED NA

Sealing Moderate Coronary Saphenous VEin Graft Lesions With Paclitaxel-Eluting Stents

NCT01223443

Coronary Artery Bypass Grafting

TERMINATED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Angina Pectoris, Variant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BVS and OMT

Optimal medical treatment + BVS implantation

Group Type EXPERIMENTAL

BVS+OMT

Intervention Type DEVICE

bioresorbable vascular scaffold implantation plus optimal medical treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BVS+OMT

bioresorbable vascular scaffold implantation plus optimal medical treatment

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 19 and more
* Vasospastic angina diagnosed by provocation test including ergonovine provocation coronary angiography or ergonovine echocardiogram
* No-ischemia producing moderate coronary artery disease(stenosis\>50%, FFR\>0.8)

Exclusion Criteria

* Ischemic coronary lesion
* Organic heart disease associated with myocardial ischemia or sudden cardiac death
* History of percutaneous coronary intervention
* Cerebrovascular diseases or peripheral disease
* NYHA III and IV
* Cardiac pacemaker or implantable defibrillator
* Pregnancy or breast feeding
* Life expectancy less than 2 years

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No